Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Repositioning Ivermectin for Covid-19 treatment: Molecular mechanisms of action against SARS-CoV-2 replication

21 Oct 2021

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Mosquito-borne diseases and control
Share to Parasites and Host Interactions
Share to Parasitic Diseases Research and Treatment

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 34687900
DOI: 10.1016/j.bbadis.2021.166294

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Repositioning Ivermectin for Covid-19 treatment: Molecular mechanisms of action against SARS-CoV-2 replicationPMID 34687900Read ↗

THE THERAPEUTIC POTENTIAL OF IVERMECTIN FOR COVID-19: A SYSTEMATIC REVIEW OF MECHANISMS AND EVIDENCESemantic proximity Read ↗

THE THERAPEUTIC POTENTIAL OF IVERMECTIN FOR COVID-19: A SYSTEMATIC REVIEW OF MECHANISMS AND EVIDENCESemantic proximity Read ↗

Research Into Potential Therapies Against COVID-19, With Focus On IvermectinSemantic proximity Read ↗

Research Into Potential Therapies Against COVID-19, With Focus On IvermectinSemantic proximity Read ↗

Exploring the Binding Efficacy of Ivermectin Against the Key Proteins of SARS-CoV-2 Pathogenesis: an in silico ApproachSemantic proximity Read ↗

Prospective mode of action of Ivermectin: SARS-CoV-2Semantic proximity Read ↗

Pharmacometric assessment of the <i>in vivo</i> antiviral activity of ivermectin in early symptomatic COVID-19Semantic proximity Read ↗

Evaluation of the Effectiveness and Safety of Adding Ivermectin to Treatment in Severe COVID-19 PatientsSemantic proximity Read ↗

Minimal impact of ivermectin on immune response and transcriptional profiles in naïve adults with mild COVID-19Semantic proximity Read ↗

The effect of early treatment with ivermectin on viral load, symptoms and humoral response in patients with mild COVID-19: a pilot, double-blind, placebo-controlled, randomized clinical trialSemantic proximity Read ↗

Classification of the present pharmaceutical agents based on the possible effective mechanism on the COVID-19 infectionSemantic proximity Read ↗

Galectin approach to lower covid transmission - Drug Development for clinical useSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.